Knockdown of ANLN could suppress the proliferation, invasion, and migration, and lead to G2/M phase arrest of BC cells, indicating a promising role for ANLN as the prognostic biomarker for BC patients [39]. This evidence concerns the gene ANLN and breast cancer.